These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 27550344

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Population pharmacokinetics of fluconazole in young infants.
    Wade KC, Wu D, Kaufman DA, Ward RM, Benjamin DK, Sullivan JE, Ramey N, Jayaraman B, Hoppu K, Adamson PC, Gastonguay MR, Barrett JS, National Institute of Child Health and Development Pediatric Pharmacology Research Unit Network.
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4043-9. PubMed ID: 18809946
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
    García-de-Lorenzo A, Luque S, Grau S, Agrifoglio A, Cachafeiro L, Herrero E, Asensio MJ, Sánchez SM, Roberts JA.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5914-21. PubMed ID: 27458229
    [Abstract] [Full Text] [Related]

  • 25. Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients.
    Sime FB, Byrne CJ, Parker S, Stuart J, Butler J, Starr T, Pandey S, Wallis SC, Lipman J, Roberts JA.
    Crit Care; 2019 Jun 06; 23(1):205. PubMed ID: 31171022
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Does Critical Illness Change Levofloxacin Pharmacokinetics?
    Roberts JA, Cotta MO, Cojutti P, Lugano M, Della Rocca G, Pea F.
    Antimicrob Agents Chemother; 2015 Dec 14; 60(3):1459-63. PubMed ID: 26666946
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacokinetic evaluation of fluconazole in critically ill patients.
    Sinnollareddy M, Peake SL, Roberts MS, Playford EG, Lipman J, Roberts JA.
    Expert Opin Drug Metab Toxicol; 2011 Nov 14; 7(11):1431-40. PubMed ID: 21883033
    [Abstract] [Full Text] [Related]

  • 31. Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients.
    Märtson AG, van der Elst KCM, Veringa A, Zijlstra JG, Beishuizen A, van der Werf TS, Kosterink JGW, Neely M, Alffenaar JW.
    Antimicrob Agents Chemother; 2020 Aug 20; 64(9):. PubMed ID: 32660990
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults.
    Wasmann RE, Ter Heine R, van Dongen EP, Burger DM, Lempers VJ, Knibbe CA, Brüggemann RJ.
    Antimicrob Agents Chemother; 2018 Jul 20; 62(7):. PubMed ID: 29712664
    [Abstract] [Full Text] [Related]

  • 34. Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing.
    Muilwijk EW, de Lange DW, Schouten JA, Wasmann RE, Ter Heine R, Burger DM, Colbers A, Haas PJ, Verweij PE, Pickkers P, Brüggemann RJ.
    Antimicrob Agents Chemother; 2020 Sep 21; 64(10):. PubMed ID: 32816723
    [Abstract] [Full Text] [Related]

  • 35. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients.
    Martial LC, Ter Heine R, Schouten JA, Hunfeld NG, van Leeuwen HJ, Verweij PE, de Lange DW, Pickkers P, Brüggemann RJ.
    Clin Pharmacokinet; 2017 Oct 21; 56(10):1197-1206. PubMed ID: 28144840
    [Abstract] [Full Text] [Related]

  • 36. Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.
    Abdul-Aziz MH, Abd Rahman AN, Mat-Nor MB, Sulaiman H, Wallis SC, Lipman J, Roberts JA, Staatz CE.
    Antimicrob Agents Chemother; 2016 Jan 21; 60(1):206-14. PubMed ID: 26482304
    [Abstract] [Full Text] [Related]

  • 37. Low Caspofungin Exposure in Patients in Intensive Care Units.
    van der Elst KC, Veringa A, Zijlstra JG, Beishuizen A, Klont R, Brummelhuis-Visser P, Uges DR, Touw DJ, Kosterink JG, van der Werf TS, Alffenaar JC.
    Antimicrob Agents Chemother; 2017 Feb 21; 61(2):. PubMed ID: 27855112
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children.
    van der Elst KC, Pereboom M, van den Heuvel ER, Kosterink JG, Schölvinck EH, Alffenaar JW.
    Clin Infect Dis; 2014 Dec 01; 59(11):1527-33. PubMed ID: 25148892
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.